Literature DB >> 16694882

THE CARDIO-CIRCULATORY EFFECTS IN MAN OF NEO-SYNEPHRIN (1-alpha-hydroxy-beta-methylamino-3-hydroxy-ethylbenzene hydrochloride).

A Keys1, A Violante.   

Abstract

Entities:  

Year:  1942        PMID： 16694882      PMCID： PMC435110          DOI： 10.1172/JCI101270

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  THE EFFECT OF PAREDRINE ON THE VENOUS SYSTEM.

Authors:  A Iglauer; M D Altschule
Journal:  J Clin Invest       Date:  1940-05       Impact factor: 14.808
  1 in total
  10 in total

Review 1.  Substitution of phenylephrine for pseudoephedrine as a nasal decongeststant. An illogical way to control methamphetamine abuse.

Authors:  Ronald Eccles
Journal:  Br J Clin Pharmacol       Date:  2006-11-20       Impact factor: 4.335

Review 2.  Intracerebral hemorrhage associated with oral phenylephrine use: a case report and review of the literature.

Authors:  Brian E Tark; Steven R Messe; Clotilde Balucani; Steven R Levine
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-08-23       Impact factor: 2.136

3.  [Side-effects of Neosynephrine].

Authors:  H W Holtmann; W Meyer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1972

4.  The late systolic murmur.

Authors:  S M Lucardie; D Durrer
Journal:  Arch Kreislaufforsch       Date:  1967-08

5.  Reduced baroreceptor sensitivity in patients with chronic obstructive pulmonary disease.

Authors:  D Patakas; G Louridas; E Kakavelas
Journal:  Thorax       Date:  1982-04       Impact factor: 9.139

Review 6.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 7.  Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.

Authors:  Y W Lam; A M Shepherd
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

Review 8.  Potential cardiovascular adverse events when phenylephrine is combined with paracetamol: simulation and narrative review.

Authors:  Hartley C Atkinson; Amanda L Potts; Brian J Anderson
Journal:  Eur J Clin Pharmacol       Date:  2015-05-29       Impact factor: 2.953

9.  Adverse Cardiovascular Effects of Phenylephrine Eye Drops Combined With Intravenous Atropine.

Authors:  Qingyu Li; Jianxin Pang; Yang Deng; Shaochong Zhang; Yong Wang; Yang Gao; Xiaoyong Yuan; Yantao Wei; Hongbin Zhang; Junlian Tan; Wei Chi; Wenjun Guo
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

10.  Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteers.

Authors:  Cathy K Gelotte; Brenda A Zimmerman
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.